“The combination of silymarin inhibition of Oatps and NASH-associated decrease in Oatp expression caused an additive increase in plasma pitavastatin AUC in the animals.”
“The combination of silymarin inhibition of Oatps and NASH‐associated decrease in Oatp expression caused an additive increase in plasma pitavastatin AUC in the animals.”